Can a better vitamin mix beat iron pills for anemia in pregnancy?
NCT ID NCT07665957
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This study tests whether a daily multiple micronutrient supplement (MMS) works better than standard iron-folic acid (IFA) pills—or a combination of both—to raise hemoglobin levels and improve newborn health. Researchers will enroll 402 pregnant women in Pakistan and follow them through delivery. The goal is to find the best nutritional strategy to prevent anemia and support healthy births.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Multiple micronutrient supplement (MMS) and iron-folic acid (IFA)
What this could lead to
If MMS works better than IFA alone, it could lead to better pregnancy nutrition guidelines and reduce anemia and poor birth outcomes in low-resource settings.
What could go wrong
This is a small, early-stage trial in one country, so results may not apply elsewhere. Supplements may not significantly outperform standard care, and compliance can be low.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY OUTCOMES are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••